Cyclophosphamide NDC 65219-135

Product information

Brand name (proprietary)

Cyclophosphamide

Generic name (nonproprietary)

cyclophosphamide

Active ingredients

Cyclophosphamide — 500 mg/25mL

Dosage form

Injection, Powder, For solution

Route

Intravenous, Oral

Labeler

Fresenius Kabi USA, LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 204555

Marketing start

Nov 17, 2023

Listing expires

Dec 31, 2026

Identifiers

Product ID 65219-135_fadfc813-11a5-415a-9d70-06c579e7619cSPL ID fadfc813-11a5-415a-9d70-06c579e7619cSPL set ID 31986d36-a1bf-4903-93a4-ce7386241ba1RxCUI 1734917, 1734919, 1734921UNII 8N3DW7272P

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N465219013520 followed by a unit qualifier and the quantity Copy

Package 65219-0135-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Other NDCs under ANDA 204555

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.